Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
American Journal of Obstetrics and Gynecology
|
January 8, 2024
Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors
Jeffrey A How, Alejandra Flores Legarreta, Katelyn F Handley, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors
Alexandra L Martin, Carmen M Anadon, Subir Biswas, et al.
Gynecologic Oncology
|
April 30, 2023
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
Katelyn F Handley, Sumit Mehta, Alexandra L Martin, et al.
Molecular Cancer Therapeutics
|
September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
Katelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Blood Advances
|
August 2, 2023
Sézary syndrome originates from heavily mutated hematopoietic progenitors
Carly M Harro, Kimberly B Sprenger, Ricardo A Chaurio, et al.
Gynecologic Oncology
|
February 26, 2022
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer
Christopher J LaFargue, Katelyn F Handley, Nicole D Fleming, et al.
JAMA Network Open
|
October 14, 2022
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
Katelyn F Handley, Travis T Sims, Nicholas W Bateman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
American Journal of Obstetrics and Gynecology
|
January 8, 2024
Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors
Jeffrey A How, Alejandra Flores Legarreta, Katelyn F Handley, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors
Alexandra L Martin, Carmen M Anadon, Subir Biswas, et al.
Gynecologic Oncology
|
April 30, 2023
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
Katelyn F Handley, Sumit Mehta, Alexandra L Martin, et al.
Molecular Cancer Therapeutics
|
September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
Katelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Blood Advances
|
August 2, 2023
Sézary syndrome originates from heavily mutated hematopoietic progenitors
Carly M Harro, Kimberly B Sprenger, Ricardo A Chaurio, et al.
Gynecologic Oncology
|
February 26, 2022
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer
Christopher J LaFargue, Katelyn F Handley, Nicole D Fleming, et al.
JAMA Network Open
|
October 14, 2022
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
Katelyn F Handley, Travis T Sims, Nicholas W Bateman, et al.
Page
of 2